BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33113619)

  • 1. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):781-797. PubMed ID: 33113619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2022 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1262-1287. PubMed ID: 36575780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
    Xu B; Hu X; Feng J; Geng C; Jin F; Li H; Li M; Li Q; Liao N; Liu D; Liu J; Liu Q; Lu J; Liu Z; Ma F; Ouyang Q; Pan Y; Shen K; Sun T; Teng Y; Tong Z; Wang B; Wang H; Wang S; Wang S; Wang T; Wang X; Wang X; Wang Y; Wang Z; Wu J; Yan M; Yang J; Yin Y; Yuan P; Zhang J; Zhang P; Zhang Q; Zheng H
    Cancer; 2020 Aug; 126 Suppl 16():3867-3882. PubMed ID: 32710660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese expert consensus on the clinical diagnosis and treatment of advanced breast carcinoma(2018)].
    Chinese Anti-Cancer Association, Committee of Breast Cancer Society
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):703-713. PubMed ID: 30293398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].
    Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1018-1031. PubMed ID: 38110310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guideline for the management path and quality control of breast cancer prevention and treatment in China's counties (2023 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):1-18. PubMed ID: 38246777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus of Chinese experts on hot issues in genetic testing of advanced breast cancer (2021 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):60-67. PubMed ID: 35073649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)].
    ; ;
    Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(6):387-403. PubMed ID: 36775264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comprehensive management guideline for breast cancer follow-up and concomitant diseases].
    Ma F; Xu BH; Shao ZM;
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):29-41. PubMed ID: 30678414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer (2020 edition)].
    National Health Commission of the People's Republic of China
    Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):561-585. PubMed ID: 32727186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulvestrant for hormone-sensitive metastatic breast cancer.
    Lee CI; Goodwin A; Wilcken N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011093. PubMed ID: 28043088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comprehensive management guideline for breast cancer follow-up and healthcare (2022 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):1-28. PubMed ID: 35073646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China(2024 edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(0):471-480. PubMed ID: 38527739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese expert consensus on diagnosis of early lung cancer (2023 Edition)].
    Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jan; 46(1):1-18. PubMed ID: 36617923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sampling survey report on Chinese physicians' cognition of the guidelines on diagnosis and treatment of colorectal cancer].
    Gao ZY; Li M; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1067-1073. PubMed ID: 33212555
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [China guideline for the screening and early detection of female breast cancer(2021, Beijing)].
    He J; Chen WQ; Li N; Shen HB; Li J; Wang Y; Li J; Tian JH; Zhou BS; ; ;
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):357-382. PubMed ID: 33902200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.